Phase II Study of Glucocerebrosidase in Patients With Gaucher Disease

Status unconfirmed · Phase 2

Conditions studied: Gaucher's Disease

In brief

OBJECTIVES: I. Evaluate the efficacy and toxicity of glucocerebrosidase enzyme therapy in patients with Gaucher disease.

Key facts

Study ID

NCT00004293

Run by

National Center for Research Resources (NCRR)

People needed

24

Starts

1999-11-01

Last updated by the study team

2005-06-24

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Pittsburgh — Pittsburgh, Pennsylvania, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.